Physician Duty and Prudence in a Time of Pandemic |
03/30/2020 - 12:00pm to 1:00pm |
Immune-Related Adverse Events: Clinical Outcomes in Melanoma and Biomarker Approaches to Understanding Mechanisms of Toxicity |
03/23/2020 - 12:00pm to 1:00pm |
Leveraging the transcriptome to improve population-specific tumor characterization and prognostication in breast cancer patients |
03/16/2020 - 12:00pm to 1:00pm |
Policy on Harassment, Discrimination and Sexual Misconduct and Reporting Disclosures |
03/09/2020 - 12:00pm to 1:00pm |
Access to new cancer drugs and managing drug costs in a fiscally constrained health care system: can both be achieved? |
03/02/2020 - 12:00pm to 1:00pm |
Improving Outcomes in Diffuse Large B-Cell Lymphoma by Understanding the Crosstalk of Tumor Oncogenic Alterations and the Immune Microenvironment |
02/24/2020 - 12:00pm to 1:00pm |
FY20 Annual Fraud Awareness and HIPAA Training |
02/17/2020 - 12:00pm to 1:00pm |
Patient Safety & Risk Reduction |
02/10/2020 - 12:00pm to 1:00pm |
Interventional Pharmacoeconomic Trials: Novels Ways to Challenge Rising Prescribing Costs |
02/03/2020 - 12:00pm to 1:00pm |
Cellular Dynamics of Multiple Myeloma |
01/27/2020 - 12:00pm to 1:00pm |